Keeps Biopharma Inc. (KOSDAQ:256940)
8,460.00
-130.00 (-1.51%)
At close: Apr 17, 2026
Keeps Biopharma Revenue
In the year 2025, Keeps Biopharma had annual revenue of 170.15B KRW with 33.36% growth. Keeps Biopharma had revenue of 45.23B in the quarter ending December 31, 2025, with 37.74% growth.
Revenue
170.15B
Revenue Growth
+33.36%
P/S Ratio
1.00
Revenue / Employee
1.56B
Employees
109
Market Cap
169.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.15B | 42.56B | 33.36% |
| Dec 31, 2024 | 127.58B | 35.45B | 38.48% |
| Dec 31, 2023 | 92.13B | 77.52B | 530.30% |
| Dec 31, 2022 | 14.62B | 10.36B | 243.08% |
| Dec 31, 2021 | 4.26B | -10.96B | -72.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Avaco | 392.90B |
| C&G Hi Tech | 196.19B |
| Osung Advanced Materials | 165.71B |
| DMS Co.,Ltd. | 155.47B |
| DEVICE CO.,Ltd | 84.08B |
| GIS Co., Ltd. | 75.81B |
| FNS TECH. | 73.66B |
| HB SOLUTION | 62.85B |